Moderna prepares the start of the corona vaccine

The first data from the study are expected in November, Moderna announced Thursday. “We are actively preparing for the launch of mRNA-1273 and have signed a number of supply agreements with governments around the world,” said CEO Stéphane Bancel. These include the US government and the European Commission concluded exploratory talks with the company.

Moderna made nearly $ 158 million in the third quarter after $ 17 million a year ago, which the company primarily owed to payments from the US Department of Health’s state organization BARDA for its corona vaccine project. Due to a significant increase in research spending, the net loss increased to $ 233.6 million from a whopping 123 million in the same period last year.